These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9257848)

  • 21. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.
    Adhikary D; Behrends U; Moosmann A; Witter K; Bornkamm GW; Mautner J
    J Exp Med; 2006 Apr; 203(4):995-1006. PubMed ID: 16549597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment and characterization of Epstein-Barr virus-specific human CD4+ T lymphocyte clones.
    Honda S; Takasaki T; Okuno K; Yasutomi M; Kurane I
    Acta Virol; 1998 Nov; 42(5):307-13. PubMed ID: 10358731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells.
    Subklewe M; Sebelin K; Block A; Meier A; Roukens A; Paludan C; Fonteneau JF; Steinman RM; Münz C
    Hum Immunol; 2005 Sep; 66(9):938-49. PubMed ID: 16360833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
    Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
    J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells.
    Kannagi M; Sugamura K; Sato H; Okochi K; Uchino H; Hinuma Y
    J Immunol; 1983 Jun; 130(6):2942-6. PubMed ID: 6189906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex.
    Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB
    J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of autologous CD4- and CD8-mediated T-cell responses against acute lymphocytic leukemia cell line using apoptotic tumor cell-loaded dendritic cells.
    Hatakeyama N; Tamura Y; Sahara H; Suzuki N; Suzuki K; Hori T; Mizue N; Torigoe T; Tsutsumi H; Sato N
    Exp Hematol; 2006 Feb; 34(2):197-207. PubMed ID: 16459188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3.
    Misko IS; Schmidt C; Moss DJ; Burrows SR; Sculley TB
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():405-9. PubMed ID: 1704413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of mucin (MUC-1) from a mini-Epstein-Barr virus in immortalized B-cells to generate tumor antigen specific cytotoxic T cells.
    Kilger E; Pecher G; Schwenk A; Hammerschmidt W
    J Gene Med; 1999; 1(2):84-92. PubMed ID: 10738572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexes.
    Levitsky V; Zhang QJ; Levitskaya J; Kurilla MG; Masucci MG
    J Immunol; 1997 Dec; 159(11):5383-90. PubMed ID: 9548478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The specificity of recognition of a cytotoxic T lymphocyte epitope.
    Burrows SR; Rodda SJ; Suhrbier A; Geysen HM; Moss DJ
    Eur J Immunol; 1992 Jan; 22(1):191-5. PubMed ID: 1370414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component.
    Misko IS; Sculley TB; Schmidt C; Moss DJ; Soszynski T; Burman K
    Cell Immunol; 1991 Feb; 132(2):295-307. PubMed ID: 1846323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides.
    Reali E; Guerrini R; Giori B; Borghi M; Marastoni M; Tomatis R; Traniello S; Masucci MG; Gavioli R
    Clin Exp Immunol; 1996 Aug; 105(2):369-75. PubMed ID: 8706347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
    Hank JA; Sondel PM
    Hum Immunol; 1984 Apr; 9(4):211-9. PubMed ID: 6201468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen.
    Misko IS; Schmidt C; Honeyman M; Soszynski TD; Sculley TB; Burrows SR; Moss DJ; Burman K
    Clin Exp Immunol; 1992 Jan; 87(1):65-70. PubMed ID: 1370774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+ T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8+ cytotoxic T cells.
    Khanolkar A; Fu Z; Underwood LJ; Bondurant KL; Rochford R; Cannon MJ
    J Immunol; 2003 Mar; 170(6):3187-94. PubMed ID: 12626577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines.
    Crotzer VL; Christian RE; Brooks JM; Shabanowitz J; Settlage RE; Marto JA; White FM; Rickinson AB; Hunt DF; Engelhard VH
    J Immunol; 2000 Jun; 164(12):6120-9. PubMed ID: 10843661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
    Burrows SR; Sculley TB; Misko IS; Schmidt C; Moss DJ
    J Exp Med; 1990 Jan; 171(1):345-9. PubMed ID: 1688611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.